๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Point-of-care Capillary HbA1c Testing for Type 2 Diabetes Screening Among At-risk Individuals in Rural Dali, China
NCT07718867Type 2 Diabetes, Pre-diabetes
The University of Hong Kong
Not applicable
720
Dali
2026-07-28
Not yet open
SHR-A1904 in Advanced Colorectal Cancer: an Exploratory Study
NCT07700719Colorectal Cancer Metastatic
Peking University Cancer Hospital & Institute
Phase 2
17
Beijing
2026-07-28
Not yet open
Phase 1 Clinical Study of GenSci155 Injection in Healthy Adults
NCT07638800Healthy Adult Trial Participants
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 1
68
Beijing
2026-07-28
Active, closed
Validation of a Deep Learning Tool for Opportunistic Osteoporosis Screening Using Routine Non-Contrast CT Scans
NCT07739628Osteoporosis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
100
Wuhan
2026-07-28
Recruiting
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
NCT07586202Carcinoma, Non-Small-Cell Lung
Janssen Research & Development, LLC
Phase 2
68
Cheng Du Shi, Chengdu, Guangzhou, Jinan, Tianjin
2026-07-28
Recruiting
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
NCT07725939Chronic Obstructive Pulmonary Disease With Chronic Bronchitis
UCB Biopharma SRL
Phase 2
402
Beijing, Chengdu, Hangzhou, Nanchang
2026-07-27
Not yet open
Nurse-led Integrated Home Service to Support Parents in Symptom Management for Children Requiring Respiratory Support
NCT07652268Children With Medical Complexity (CMC), Symptom Management, Nurse-led Supportive Care, Self Efficacy
Dr Winsome Lam
Not applicable
80
Hong Kong
2026-07-27
Recruiting
A Study to Evaluate GFH375 Versus Docetaxel in Participants With Non-Small Cell Lung Cancer With KRAS G12D Mutation
NCT07668752KRAS G12D Mutation, NSCLC (Non-small Cell Lung Cancer)
Genfleet Therapeutics (Shanghai) Inc.
Phase 3
300
Shanghai
2026-07-27
Not yet open
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Oral SAL0137 in Adults With Elevated Lp(a) and Increased Risk of Cardiovascular Events
NCT07729475Elevated Lipoprotein(a)
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 2
120
Beijing
2026-07-27
Active, closed
Chidamide in HR-AML
NCT07822789Acute Myeloid Leukemia, Maintenance Therapy
Guangdong Second Provincial General Hospital
Observational
33
Guangzhou
2026-07-27
Recruiting
A Phase II Study to Evaluate the Efficacy and Safety of SKB571 in Recurrent or Metastatic HNSCC Participants
NCT07668154HNSCC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 2
120
Chengdu, Shanghai
2026-07-27
Not yet open
The COMBINE-AF Trial
NCT07633509Atrial Fibrillation (AF), Atrial Fibrillation Catheter Ablation
Yunlong Wang
Not applicable
430
Beijing, Nanjing
2026-07-27
Recruiting
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
NCT07497087Systemic Sclerosis
Boehringer Ingelheim
Phase 3
448
Beijing, Changchun, Changsha, Chengdu, Guangzhou, Hangzhou, Hefei, Luoyang
2026-07-27
Recruiting
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
NCT07492680Solid Tumors
Bristol-Myers Squibb
Phase 2
260
Beijing, Chongqing, Guangzhou, Xinxiang, Shanghai
2026-07-27
Recruiting
STN-tTIS With Different Intervention Intervals Versus Standard Medical Treatment for Parkinson's Disease
NCT07774312Parkinson's Disease (PD)
Ruijin Hospital
Not applicable
60
Shanghai
2026-07-27
Not yet open
Recurrence After Gastric and Intestinal Polyp Resection
NCT07314554Gastric Polyps, Intestinal Polyps, Colon Polyps, Colorectal Polyps
LanZhou University
Observational
2,000
Lanzhou
2026-07-26
Not yet open
Tracking Risk in Adolescents and Children for Early Identification of Common Mental Disorders
NCT07744490High Risk, Depression / Major Depressive Disorder, Anxiety Disease, Obsessive - Compulsive Disorder
Shanghai Mental Health Center
Observational
200
Shanghai
2026-07-25
Recruiting
Hypofractionated Radiotherapy Plus GM-CSF, Pomalidomide and Glofitamab for Newly Diagnosed PCNS-DLBCL
NCT07749365DLBCL - Diffuse Large B Cell Lymphoma, PCNSL (Primary CNS Lymphoma)
The First Affiliated Hospital of Xiamen University
Phase 2
53
Xiamen
2026-07-25
Recruiting
A Study to Evaluate 20vPnC in Healthy Chinese Infants
NCT07754539Pneumococcal Diseases
Pfizer
Phase 3
1,250
Hezhou, Nanning, Zhongshan Town
2026-07-25
Recruiting
Individualized Primary Clinical Target Volume Based on Margin Expansion for Nasopharyngeal Carcinoma
NCT07661771Non-metastatic Nasopharyngeal Carcinoma
Sun Yat-sen University
Phase 3
568
Dongguan, Foshan, Guangzhou, Shenzhen, Zhongshan, Changsha
2026-07-24
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of HRS9531 Tablets in Overweight or Obese Subjects
NCT07670884Chronic Management of Body Weight
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
675
Zhengzhou, Nanjing
2026-07-24
Recruiting
68Ga-SorB PET/CT Imaging in Patients With Solid Tumors
NCT07760012Melanoma (Skin Cancer), Hepatocellular Carcinoma, Lung Cancer, Breast Cancer
Peking University Third Hospital
Not applicable
50
Beijing
2026-07-24
Recruiting
Adults With Constipation
NCT07529457Constipation
Wecare Probiotics Co., Ltd.
Not applicable
70
Suzhou
2026-07-24
Recruiting
A Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer(PANKU-Lung09)
NCT07642024Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2/3
90
Shanghai
2026-07-24
Recruiting
Metronomic Oral Paclitaxel Plus PD-1/ PD-L1 Inhibitor Maintenance in Advanced Lung Cancer (PULSE Study)
NCT07744698Squamous Non-Small Cell Lung Cancer sqNSCLC, Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Anhui Provincial Cancer Hospital
Phase 4
107
Hefei
2026-07-24
Recruiting
A Study of Ferric Derisomaltose Injection in Chinese Participants With Iron Deficiency Anemia Under Fasting Conditions
NCT07790562Iron Deficiency Anemia
Sichuan Huiyu Pharmaceutical Co., Ltd
Phase 1
88
Zhengzhou
2026-07-23
Recruiting
A Clinical Study of SHR-5421 in Patients With Multiple Myeloma
NCT07652281Multiple Myeloma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
97
Beijing
2026-07-23
Recruiting
Bevacizumab, Sintilimab, Cetuximab and Irinotecan in Refractory RAS Wild-type Metastatic Colorectal Cancer: BOND-4 Trial
NCT07722754Colorectal Neoplasms Malignant, Neoplasm, Metastatic
Guangdong Provincial People's Hospital
Phase 2
160
Guangzhou
2026-07-23
Recruiting
A Clinical Study of SHR-3079 in B-cell Non-Hodgkin Lymphoma
NCT07661537B-cell Non-Hodgkin Lymphoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
90
Beijing, Guangzhou
2026-07-23
Recruiting
Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China
NCT07757152Healthy Participants Study
Chengdu Zenitar Biomedical Technology Co., Ltd
Phase 1
108
Chengdu
2026-07-23
Not yet open
Benson Relaxation for Anxiety and Depression After Stroke
NCT07731282Ischemic Stroke, Acute, Post-stroke Anxiety, Post-stroke Depression
Geng Nannan
Not applicable
74
Changchun
2026-07-23
Recruiting
Single-port Robotic Radical Gastrectomy for Gastric Cancer
NCT07237126Gastric Cancer Patients Undergoing Gastrectomy
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not applicable
20
Chongqing
2026-07-22
Recruiting
Hyperbaric Oxygen After Stroke Thrombectomy: A Multicenter Randomized Trial on Safety and Efficacy
NCT07049692Acute Ischemic Stroke
Beijing Chao Yang Hospital
Not applicable
424
Beijing
2026-07-22
Recruiting
Maintenance Immunotherapy With Deferred Salvage Radiotherapy After Response to Chemoimmunotherapy in Recurrent Nasopharyngeal Carcinoma
NCT07528183Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 2
62
Fuzhou, Guangzhou, Nanning, Wuhan
2026-07-22
Not yet open
Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM
NCT07728019CRC (Colorectal Cancer)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
60
Wuhan
2026-07-22
Not yet open
A Study of Glofitamab Plus GemOx Compared With Standard of Care in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT07599423Diffuse Large B Cell Lymphoma (DLBCL)
The First Affiliated Hospital of Soochow University
Phase 2
96
Suzhou
2026-07-22
Not yet open
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAL0167 in Healthy Participants
NCT07722299Hyperlipidemia
Shenzhen Salubris Pharmaceuticals Co., Ltd.
Phase 1
120
Guangzhou
2026-07-21
Recruiting
Safety, Tolerability, and Preliminary Efficacy of [211At]MABG in Patients With Relapsed or Refractory Neuroblastoma
NCT07767630Neuroblastoma (NB)
Sichuan University
Phase EARLY_PHASE1
10
Chengdu
2026-07-21
Recruiting
A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes
NCT07668999Tinea Pedis
Sinomune Pharmaceutical Co., Ltd
Phase 1
64
Beijing
2026-07-21
Recruiting
Nonintubated Anesthesia for Adult Cardiac Surgery With Cardiopulmonary Bypass
NCT07744009Valve Disease, Heart, CABG
The First Affiliated Hospital of Guangzhou Medical University
Not applicable
300
Guangzhou
2026-07-21
Recruiting
A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)
NCT07366034Fibrosing Interstitial Lung Disease
Boehringer Ingelheim
Phase 3
35
Beijing, Changsha, Shanghai
2026-07-21
Recruiting
A Phase I Clinical Trial to Evaluate CMS-F021 Following Single and Multiple Doses in Healthy Participants
NCT07790770Superficial Skin and Soft Tissue Infections Caused by Gram-positive Bacteria
Dermavon Holdings Limited
Phase 1
72
Beijing
2026-07-21
Recruiting
Study on the Safety and Efficacy of Polymyxin E2 Methanesulfonate for Injection in the Treatment of Hospital-Acquired Bacterial Pneumonia/Ventilator-Associated Bacterial Pneumonia Caused by Carbapenem-Resistant Gram-Negative Bacteria
NCT07512596Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 2
48
Bengbu, Beijing, Chongqing, Foshan, Guangzhou, Shenzhen, Zhuhai, Shijiazhuang
2026-07-21
Not yet open
QLESP Block for Pain Control in Robotic Partial Nephrectomy
NCT07704970Renal Cell Carcinoma (Kidney Cancer), Postoperative Pain, Nerve Block
Huazhong University of Science and Technology
Not applicable
120
Wuhan
2026-07-20
Recruiting
Ipsilateral Versus Bilateral Systematic Biopsy Combined With MRI/Ultrasound Cognitive Fusion Targeted Biopsy for Prostate Cancer Diagnosis
NCT07795723Prostate Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
454
Nanjing
2026-07-20
Active, closed
Dynamic Monitoring of Urinary Electrolytes
NCT07704450Healthy
Westlake University
Not applicable
40
Hangzhou
2026-07-20
Recruiting
Different Frequency Temporal Interference Stimulation on Bilateral Subthalamic Nucleus for Parkinson's Disease
NCT07721688Parkinson Disease (PD)
Ke Dong, MD
Not applicable
40
Guangzhou
2026-07-20
Recruiting
Effects of Alternating Altitude Training Versus Fixed-Altitude Training on Exercise Capacity and Physiological Adaptations in Elite Race Walkers: A Randomized Controlled Trial
NCT07718009Altitude Training, Race Walking
Macao Polytechnic University
Not applicable
16
Macao
2026-07-20
Recruiting
ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea
NCT07767370Diarrhea Chronic, UC - Ulcerative Colitis
The Second Hospital of Nanjing Medical University
Phase EARLY_PHASE1
36
Nanjing
2026-07-20
Recruiting
Efficacy and Safety of Becotatug Vedotin (MRG003) Combined With Anti-PD1 as Maintenance Therapy for Recurrent and Metastatic Nasopharyngeal Carcinoma
NCT07705243Nasopharyngeal Cancinoma (NPC)
Sun Yat-sen University
Phase 3
86
Guangzhou
2026-07-20
Recruiting
Study on the Effect of Fecal Microbiota Transplantation on Eradication of Refractory Helicobacter Pylori Infection
NCT07704255Helicobacter Pylori Infection
Sichuan Provincial People's Hospital
Phase 4
10
Chengdu
2026-07-20
Not yet open
Pre-procedural Risk Score-Based Endoscopist Assignment for Pain Reduction in Unsedated Colonoscopy
NCT07713953Colonoscopy Pain
Ningbo No. 1 Hospital
Not applicable
106
Ningbo
2026-07-20
Recruiting
A Study of NWRD09 in Participants With Persistent HPV16 Infection in the Anal Region
NCT07710664Persistent HPV16 Infection
Newish Biotech (Wuxi) Co., Ltd.
Phase 1
10
Beijing
2026-07-20
Not yet open
AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes
NCT07697391Obesity, Diabetes Mellitus, Type 2
The First Affiliated Hospital of Anhui Medical University
Phase 4
285
Hefei
2026-07-20
Recruiting
Efficacy and Safety of Superior Vena Cava Isolation and Pulmonary Vein Isolation for Treatment of Atrial Fibrillation
NCT07724899Atrial Fibrillation (AF)
Qiang Hu
Not applicable
200
Chengdu
2026-07-20
Recruiting
QL1706๏ผˆIparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Biliary Tract Cancer
NCT07733115Biliary Tract Cancer (BTC)
Shanghai Zhongshan Hospital
Phase 2
38
Shanghai
2026-07-20
Recruiting
Efficacy and Safety of Ravulizumab in Chinese Adults Participants With Generalized Myasthenia Gravis (gMG)
NCT07596784Generalized Myasthenia Gravis, gMG
Alexion Pharmaceuticals, Inc.
Phase 3
20
Beijing, Changchun, Fuzhou, Jinan, Shanghai, Shijiazhuang, Taiyuan, Tianjin
2026-07-20
Active, closed
Study to Evaluate the Effect of Rabeprazole Sodium Enteric-coated Tablets on the Pharmacokinetics of TQ05105 Tablets
NCT07608666Myelofibrosis
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
17
Changsha
2026-07-20
Not yet open
A Study of KIV-318 Injection in Patients With BCMA-Positive Relapsed/Refractory Multiple Myeloma
NCT07726160Relapse and/or Refractory Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China
Phase 1
30
Tianjin
2026-07-20
Recruiting
Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT07557420NMOSD, Neuromyelitis Optica Spectrum Disorder
Alexion Pharmaceuticals, Inc.
Phase 3
19
Beijing, Chengdu, Dongguan, Jinan, Shanghai, Shijiazhuang, Taiyuan, Wenzhou
2026-07-20
Not yet open
BCMA/GPRC5D Trispecific Antibody Treatment for Newly Diagnosed Amyloidosis (AL-004)
NCT07751471AL Amyloidosis
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
20
Tianjin
2026-07-20
Recruiting
A Multicenter Prospective Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in NMOSD
NCT07762872Neuromyelitis Optica Spectrum Disorders (NMOSD)
Junwei Hao, MD
Observational
50
Beijing
2026-07-20
Recruiting
Aspirin Monotherapy Versus Sequential Warfarin-Aspirin Therapy After TAVR in Patients With Pure Aortic Regurgitation
NCT07677410Aortic Regurgitation Disease
Shanghai Zhongshan Hospital
Not applicable
1,172
Shanghai
2026-07-18
Not yet open
A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults
NCT07697846Overweight, Obesity
Beijing QL Biopharmaceutical Co.,Ltd
Phase 1
40
Beijing
2026-07-18
Not yet open
Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)
NCT07713745Neurofibromatosis Type 2, Vestibular Schwannoma, Non-vestibular Schwannoma, Meningioma
Beijing Tiantan Hospital
Phase 2
200
Beijing, Changchun, Shanghai
2026-07-18
Recruiting
Perioperative Transcutaneous Fluorescence Detection of GFR Trajectory for the Early Prediction and Diagnosis of CSA-AKI.
NCT07749417Acute Kidney Injury
China National Center for Cardiovascular Diseases
Observational
436
Beijing
2026-07-17
Recruiting
Remimazolam Combined With Oliceridine for Sedation in Elderly Patients Undergoing Gastrointestinal Endoscopy
NCT07707258Sedation, Gastrointestinal Endoscopy
Baoshan Branch, Renji Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
240
Shanghai
2026-07-17
Recruiting
Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
NCT07606950Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
Fujian Shengdi Pharmaceutical Co., Ltd.
Phase 3
540
Guangzhou
2026-07-17
Recruiting
A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer
NCT07591090Advanced Breast Cancer
Akeso
Phase 2
200
Shanghai
2026-07-17
Recruiting
SSGJ-705 Plus SSGJ-612 ยฑ Chemotherapy in Advanced HER2-Expressing Solid Tumors
NCT07646626Locally Advanced (Unresectable) or Metastatic Solid Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.
Phase 2
150
Hangzhou
2026-07-17
Recruiting
VG081821AC Tablets for Early to Mid-stage Parkinson's Disease
NCT07725562Parkinson Disease (PD)
Zhejiang Vimgreen Pharmaceuticals, Ltd.
Phase 2/3
152
Beijing
2026-07-17
Recruiting
A Phase I Trial of GW01-200 Tablets in Subjects With Advanced Tumors
NCT07629258Advanced Tumors
Groovy Medicine (Hangzhou) Ltd.
Phase 1
100
Beijing, Langfang, Hangzhou
2026-07-17
Active, closed
LEAF (Liver Tumor dEtection And classiFication AI)
NCT06859840Liver Malignancy
Zhejiang University
Not applicable
2,500
Hangzhou
2026-07-17
Recruiting
AI-Optimized Single-Feature Recognition Model for Heart Failure
NCT07667452Cardiac Sound, Heart Failure - NYHA II - IV
Vivalink
Observational
50
Hangzhou
2026-07-16
Recruiting
A Phase I Study of CS5007 in Participants With Advanced Solid Tumors
NCT07622524Advanced Solid Tumors
CStone Pharmaceuticals
Phase 1
310
Shanghai
2026-07-16
Recruiting
Single-Lead ECG Conduction Interval Algorithm
NCT07667465Conduction of Electrocardiogram
Vivalink
Observational
50
Hangzhou
2026-07-16
Recruiting
Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
NCT07640295Metastatic Pancreatic Ductal Adenocarcinoma
Jacobio Pharmaceuticals Co., Ltd.
Phase 1/2
80
Beijing, Hangzhou, Changsha, Harbin, Nanjing, Shanghai, Taiyuan, Wuhan
2026-07-16
Recruiting
Endovascular Treatment for Posterior Circulation Ischemic Stroke Post 1 Day ๏ผˆ24 Hours๏ผ‰
NCT07699029Posterior Circulation Ischemic Stroke
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not applicable
244
Wuhan
2026-07-16
Not yet open
SMP-656 for HER2-Positive Advanced Breast Cancer
NCT07726342HER2-positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer (LABC)
Chengdu SciMount Pharmatech Co., Ltd.
Phase 2
60
Hefei, Beijing, Guangzhou, Shijiazhuang, Zhengzhou, Wuhan, Changsha, Nanjing
2026-07-16
Recruiting
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
NCT07406035Psoriatic Arthritis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
156
Bozhou, Beijing, Chongqing, Dongguan, Guangzhou, Jiangmen, Shenzhen, Nanning
2026-07-16
Recruiting
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
NCT07720284High-risk Muscle Invasive Urothelial Carcinoma
AstraZeneca
Phase 3
915
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hangzhou
2026-07-16
Not yet open
Neoadjuvant SHR-A1811 and SHR-A1701 ยฑ Pertuzumab for Potentially Immunotherapy-Sensitive GC or GEJ Adenocarcinoma
NCT07716111Gastric or Gastroesophageal Junction Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University
Phase 2
24
Nanjing
2026-07-16
Recruiting
Safety and Efficacy of KSVCBD Injection in B-cell Non-Hodgkin's Lymphoma Expressing CD19 and/or BCMA
NCT07620314Non-Hodgkin's Lymphoma
Chinese PLA General Hospital
Phase 1
9
Beijing
2026-07-16
Recruiting
Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
NCT07693426Adolescence Obesity
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Phase 1
36
Beijing, Wuhan, Shenyang, Jinan
2026-07-16
Not yet open
Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
NCT07711678Obstructive Sleep Apnea (OSA), Syndrome, Obstructive Sleep Apnea, Respiration Disorders, Sleep Apnea Syndrome, Obstructive
Beijing Pins Medical Co., Ltd
Not applicable
10
Beijing
2026-07-15
Recruiting
A Phase I/II Clinical Study to Evaluate SKG0201 Injection in Subjects With Spinal Muscular Atrophy Type I
NCT07554924Spinal Muscular Atrophy 1
Lanyue Biotech (Hangzhou) Co., Ltd.
Phase 1/2
11
Beijing, Shanghai, Hangzhou
2026-07-15
Recruiting
Digital Mindfulness-Based Therapy for Obsessive-Compulsive Disorder
NCT07701616Obsessive-Compulsive Disorder
Central South University
Not applicable
150
Changsha
2026-07-15
Not yet open
EIT Evaluation of Different Antihypertensive Agents on the Ventilation-Perfusion Ratio in Patients With Acute Respiratory Failure
NCT07603037Acute Respiratory Failure (ARF), Hypertension, Pulmonary Perfusion Imbalance, Aortic Dissection (Subset)
First Affiliated Hospital of Wannan Medical College
Not applicable
12
Wuhu
2026-07-15
Not yet open
Bionic Balloon-assisted Delivery Technology on the Labor Process
NCT07707804Vaginal Delivery
Peking Union Medical College Hospital
Not applicable
300
Cangzhou, Beijing
2026-07-15
Recruiting
Implantable Wireless Brain-Computer Interface Systems in Patients With Tetraplegia
NCT07784088Spinal Cord Injury Cervical, Tetraplegia/Tetraparesis, Spinal Cord Injuries (SCI)
BCIFlex Medical Technology Co., Ltd.
Not applicable
34
Beijing
2026-07-15
Not yet open
Younger vs. Older Donors in Allo-HSCT: TTE
NCT07666568A Target Trial Emulation Study, Donor Age, ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
The First Affiliated Hospital of Soochow University
Observational
5,000
Suzhou
2026-07-15
Not yet open
Superoxide Dismutase Skin Spray for the Prevention of Acute Radiation Dermatitis in Head and Neck Cancer
NCT07704372Radiation-induced Dermatitis
West China Hospital
Phase 2
140
Chengdu
2026-07-15
Rows per page Showing 1101–1200 of 19052
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=12

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.